INVEX THERAPEUTICS LTD - Charts / Financials

Market Cap $6.012M Add to my watchlist

Healthcare

Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical... Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure. Our primary focus is on the orphan disease Idiopathic Intracranial Hypertension (IIH), a large and growing market opportunity with no regulatory cleared treatmentsMore

REFRESH

Last update - 16.20pm 02/05/2024 (20 minute delay)

Day
Open	8.2¢		Day High	8.2¢		Day Low	8.0¢
Daily Volume	6987

Bids				Sellers
Number	Price	Volume		Number	Price	Volume
1	8.0¢	28219		1	8.6¢	2202

Directors & Senior Management

Ms. Narelle Warren	Chief Financial Officer, Company Secretary
Ms. Carol Parish	Chief Operating Officer
Dr. Thomas Duthy	Executive Director
Mr. David Mcauliffe	Interim Non-Executive Chairman of the Board
Mr. David Colin Wheeler	Non-Executive Director
Dr. Megan Baldwin	Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last 8.0¢		Change -0.002(2.44%)		Mkt cap ! $6.012M

Open	High	Low	Value	Volume
8.2¢	8.2¢	8.0¢	$572	6.987K

Buyers (Bids)

No.	Vol.	Price($)
1	28219	8.0¢

Sellers (Offers)

Price($)	Vol.	No.
8.6¢	2202	1

View Market Depth

No.	Vol.	Price($)
1	28219	0.080
1	100000	0.070
1	32000	0.060
2	60001	0.047
2	100001	0.038

Price($)	Vol.	No.
0.086	2202	1
0.090	126146	1
0.095	100000	1
0.100	76646	2
0.110	100000	1

Last trade - 15.34pm 02/05/2024 (20 minute delay)

IXC (ASX) Chart

INVEX THERAPEUTICS LTD - Charts / Financials

Directors & Senior Management

Buyers (Bids)

Sellers (Offers)

Top Stories